2005
DOI: 10.1161/circulationaha.105.584623
|View full text |Cite
|
Sign up to set email alerts
|

Decreased Perivascular Fibrosis but Not Cardiac Hypertrophy in ROCK1 +/− Haploinsufficient Mice

Abstract: Background-Rho GTPase and its downstream target, Rho-associated kinase (ROCK), have been implicated in diverse cardiovascular diseases such as cardiac hypertrophy. However, pharmacological inhibitors of ROCK are not entirely specific, nor can they discriminate between the ROCK isoforms ROCK1 and ROCK2. To determine the specific role of ROCK1 in the development of cardiac hypertrophy, we generated ROCK1 ϩ/Ϫ haploinsufficient mice and determined whether cardiac hypertrophy and remodeling are decreased in these m… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

9
186
2
1

Year Published

2007
2007
2023
2023

Publication Types

Select...
6
1
1

Relationship

1
7

Authors

Journals

citations
Cited by 193 publications
(198 citation statements)
references
References 26 publications
9
186
2
1
Order By: Relevance
“…97,98 Indeed, the RhoA/ROCK pathway has been shown to be involved in the formation of atherosclerotic lesions, vasoconstriction and myocardial hypertrophy and to be activated in patients with hypertension and in patients with coronary artery disease. [99][100][101][102][103][104] Recently, we have shown that FMD is an independent predictor of leukocyte ROCK activity in healthy men and men with cardiovascular risk factors but without established cardiovascular or cerebrovascular diseases, suggesting that cumulative cardiovascular risk, including aging and hypertension, may enhance ROCK activity and endothelial dysfunction. 105 Activation of the RhoA/ROCK pathway impairs NO bioavailability through inhibition of eNOS mRNA stability, eNOS posphorylation at Ser 1177 and the Akt/PI3K pathway and enhancement of eNOS phosphorylation at Thr495.…”
Section: Tetrahydrobiopterin (Bh 4 )mentioning
confidence: 99%
“…97,98 Indeed, the RhoA/ROCK pathway has been shown to be involved in the formation of atherosclerotic lesions, vasoconstriction and myocardial hypertrophy and to be activated in patients with hypertension and in patients with coronary artery disease. [99][100][101][102][103][104] Recently, we have shown that FMD is an independent predictor of leukocyte ROCK activity in healthy men and men with cardiovascular risk factors but without established cardiovascular or cerebrovascular diseases, suggesting that cumulative cardiovascular risk, including aging and hypertension, may enhance ROCK activity and endothelial dysfunction. 105 Activation of the RhoA/ROCK pathway impairs NO bioavailability through inhibition of eNOS mRNA stability, eNOS posphorylation at Ser 1177 and the Akt/PI3K pathway and enhancement of eNOS phosphorylation at Thr495.…”
Section: Tetrahydrobiopterin (Bh 4 )mentioning
confidence: 99%
“…Recently ROCK1-knockout (ROCK1 -/-) and ROCK2-knockout (ROCK2 -/-) mice have been generated [115,122,135,153] and their phenotypes are different. ROCK1 -/-mice under C57BL/ 6N genetic background exhibit eyelid open at birth (EOB) and omphalocele phenotype due to disorganization of actin filament in the epithelial cells of the eyelid and of the umbilical ring [122].…”
Section: Rock1-and Rock2-knockout Micementioning
confidence: 99%
“…The genetic background may also affect the EOB and omphalocele phenotype in ROCK1 -/-mice, as this phenotype was not observed in ROCK1 -/-mice under the mixed C57BL/6N-129/ SvJ or FVB background [153], although the differences in targeting vector may also contribute to the different phenotype of ROCK1 -/-mice generated by different laboratories [115,122,153]. In addition, the ROCK1 -/-mice under FVB background have no detected anatomical abnormalities from embryonic day 9.5 to adulthood, although they are underrepresented, possibly due to lethality at very early developmental stages [153].…”
Section: Rock1-and Rock2-knockout Micementioning
confidence: 99%
“…The two ROCK paralogs share 65% identity overall and 92% identity in their kinase domains [32] and ROCK1 & 2 knockout mice display unique phenotypes [3, 5-7], suggesting that their regulation and signaling may be divergent to a measurable degree. Indeed, comparisons of RNAi knockdowns of the individual ROCK paralogs across a handful of cell types uncovered unique roles for each paralog in actin organization, migration, cellular morphogenesis, cell cycle progression, apoptosis, and extracellular matrix assembly [8-10, 12, 13, 33].…”
Section: Discussionmentioning
confidence: 99%
“…ROCK1(-/-) mice result in lethality soon after birth, displaying failure of eyelid and ventral body wall closure [3], while ROCK2(-/-) mice experience embryonic lethality due to interuterine growth retardation and placental dysfunction [4]. Viable fertile litters have been reported for ROCK1(+/-) and ROCK2(+/-) mice, however ROCK1(+/-) mice exhibit increased resistance to perivascular fibrosis and reduced vascular injury-induced neointima formation [5, 6], while ROCK2(+/-) mice display decreased platelet endothelial cell adhesion molecule staining of endothelial cells in the lung [7]. Only a handful of recent reports have utilized RNAi technology to singularly disrupt each ROCK paralog in vitro , demonstrating unique roles for each protein in the control of actin-cytoskeleton dynamics and cell morphogenesis, migration, cell fate decisions, and extracellular matrix assembly [7-13].…”
Section: Introductionmentioning
confidence: 99%